The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous DesmoteplaseStroke 36:66-73, Hacke,W.,et al, 2005